The Effect of Pranayama on Pain and Respiration After Coronary Bypass Surgery
The Effect of Pranayama and Pursed Lip Breathing Exercise on Pain and Respiration After Coronary Bypass Surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Şehitkamil
-
Gaziantep, Şehitkamil, Turkey, 27310
- Tuğba Albayram
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- CABG surgery performed on a stopped heart (On pump),
- Cardiopulmonary risk index score ≤2
- Those aged 18 and over,
- Being literate and communicative,
- American Society of Anesthesiologists (ASA) classification I or II,
- Preoperative respiratory function tests with normal FEV1, FVC, FEV1/FVC values,
- No complications developed during and after the surgical intervention,
- An analgesic drug with the same active ingredient is applied to control pain after surgical intervention,
- Patients who were administered antibiotics with the same active ingredient after surgical intervention were included.
Exclusion Criteria:
- CABG surgery performed on a working heart (off-pump),
- Cardiopulmonary risk index score ≥4
- Complications developing during or after surgery,
- Intubated,
- Those with chronic pain in the pre-surgical period,
- Those with limited movement activity before surgery,
- Having a body mass index (BMI≥30),
- Patients who could not adapt to and tolerate the pranayama technique were not included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Pranayama
Nadi Shothana Pranayama was applied to the patients for 15 minutes before the surgery and for 7 days after the surgery.
After the application, FVC, FEV1, and FEV1/FVC values were measured with a spirometer (Contec Spirometer SP70B, Contec Medical Systems Co,.
Ltd., China) and recorded in the Patient Follow-up Form.
In cases where the patient did not perform well, the measurement was repeated at least three times and the best data was taken.
Systolic and diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation, which were thought to affect the results of FVC, FEV1, and FEV1/FVC values, were also measured and recorded.
In addition, hematocrit level, analgesia dose, and amounts used during the day were recorded daily and in the Patient Follow-up Form.
Pain levels were evaluated 4 times daily (10:00-14:00-22:00-06:00) during the 0th to 6th days after surgery and recorded on the Visual Analog Scale Form.
|
Pranamaya
|
|
Sham Comparator: Pursed Lips Breathing
Pursed Lip Breathing Exercise was applied to the patients before and after the surgery for 15 minutes.
After the application, FVC, FEV1, and FEV1/FVC values were measured with a spirometer (Contec Spirometer SP70B, Contec Medical Systems Co., Ltd., China) and recorded in the Patient Follow-up Form.
(Annex-3).
In cases where the patient did not perform well, the measurement was repeated at least three times and the best data was taken.
Systolic and diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation, which are thought to affect the results of FVC, FEV1, and FEV1/FVC values, were also measured and recorded before and after the application.
In addition, hematocrit level, analgesia dose, and amounts used during the day were recorded daily and in the Patient Follow-up Form.
Pain levels were evaluated 4 times daily (10:00-14:00-22:00-06:00) during the 0th to 6th days after surgery and recorded on the Visual Analog Scale Form.
|
Pursed Lips Breathing
|
|
No Intervention: Control
No intervention was made to the control group patients.
FVC, FEV1 and FEV1/FVC values of the patients were measured with a spirometer (Contec Spirometer SP70B, Contec Medical Systems Co., Ltd., China) before the surgery and for 7 days after the surgery.
In cases where the patient did not perform well, the measurement was repeated at least three times and the best data was taken.
Systolic and diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation, which are thought to affect the results of FVC, FEV1, and FEV1/FVC values, were also measured and recorded at 15-minute intervals.
In addition, the hematocrit level, the dose, and amount of analgesia used during the day were recorded daily and in the Patient Follow-up Form.
Pain levels were evaluated 4 times daily (10:00-14:00-22:00-06:00) during the 0th to 6th days after surgery and recorded on the Visual Analog Scale Form.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative FVC
Time Frame: From admission to discharge, up to 1 week
|
Improvement in FVC in patients treated with Pranayama after CABG
|
From admission to discharge, up to 1 week
|
|
FEV1
Time Frame: From admission to discharge, up to 1 week
|
Improvement in FEV1 in patients treated with Pranayama after CABG
|
From admission to discharge, up to 1 week
|
|
FEV1/FVC level
Time Frame: From admission to discharge, up to 1 week
|
Improvement in FEV1/FVC level in patients treated with Pranayama after CABG
|
From admission to discharge, up to 1 week
|
|
Change in postoperative pain measured by VAS
Time Frame: From surgery to 3 days after surgery
|
Change in postoperative pain measured by VAS in patients who underwent pranayama after CABG
|
From surgery to 3 days after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Tuğba Albayram, University of Gaziantep
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TALBAYRAM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.